Cancer

Opdivo approval expanded to include lung cancer

(HealthDay)—U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small cell lung cancer (NSCLC), the agency said Wednesday in a news release.

8 hours ago
popularity not rated yet | comments 0

First-of-its kind reference on pelvic malignancies

Loyola University Medical Center radiation oncologist William Small, Jr., MD, FACRO, FACR, FASTRO, is co-editor of Pelvic Malignancy and its Consequences, the first-of-its kind stand-alone reference on the subject.

9 hours ago
popularity not rated yet | comments 0

Genetic modification aids cancer drug discovery

Genetically modifying cancer cells can aid in clarifying new cancer drugs' mechanism of action, according to a new study by researchers at KU Leuven's Laboratory of Virology and Chemotherapy (Rega Institute).

18 hours ago
popularity not rated yet | comments 0

Protein may be key to cancer's deadly resurgences

Tumor recurrence following a period of remission is the main cause of death in cancer. The ability of cancer cells to remain dormant during and following therapy, only to be reactivated at a later time, frequently ...

Mar 03, 2015
popularity 4.6 / 5 (5) | comments 1

How much overdetection is acceptable in cancer screening?

People have highly variable views on how much overdetection is acceptable in cancer screening, finds a UK survey in The BMJ this week. The authors say invitations for screening "should include clear information on the li ...

Mar 03, 2015
popularity not rated yet | comments 0

Study shows why some brain cancers resist treatment

Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.

Mar 02, 2015
popularity 5 / 5 (3) | comments 0